Discontinued — last reported Q3 '24

Business Segments · CapEx

Life Sciences and Applied Markets — CapEx

Agilent Technologies Life Sciences and Applied Markets — CapEx remained flat by 0.0% to $15.00M in Q3 2024 compared to the prior quarter. Year-over-year, this metric declined by 14.3%, from $17.50M to $15.00M. Over 2 years (FY 2022 to FY 2024), Life Sciences and Applied Markets — CapEx shows a downward trend with a -11.7% CAGR.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2021
Last reportedQ3 2024

How to read this metric

An increase suggests management is investing in capacity expansion or modernization, while a decrease may indicate a focus on cash preservation or a shift toward asset-light operations.

Detailed definition

This metric represents the cash outflows used by the Life Sciences and Applied Markets segment to acquire, upgrade, and...

Peer comparison

Peer companies in the life sciences and diagnostics sector typically report this as 'Capital Expenditures' or 'Property, Plant, and Equipment Additions' within their segment disclosures.

Metric ID: a_segment_life_sciences_and_applied_markets_capital_expenditures

Historical Data

3 years
 FY'22FY'23FY'24
Value$77.00M$70.00M$60.00M
YoY Change-9.1%-14.3%
Range$60.00M$77.00M
CAGR-11.7%
Avg YoY Growth-11.7%
Median YoY Growth-11.7%
Current Streak2+ years decline

Frequently Asked Questions

What is Agilent Technologies's life sciences and applied markets — capex?
Agilent Technologies (A) reported life sciences and applied markets — capex of $15.00M in Q3 2024.
How has Agilent Technologies's life sciences and applied markets — capex changed year-over-year?
Agilent Technologies's life sciences and applied markets — capex decreased by 14.3% year-over-year, from $17.50M to $15.00M.
What is the long-term trend for Agilent Technologies's life sciences and applied markets — capex?
Over 2 years (2022 to 2024), Agilent Technologies's life sciences and applied markets — capex has grown at a -11.7% compound annual growth rate (CAGR), from $77.00M to $60.00M.
What does life sciences and applied markets — capex mean?
The amount of money the segment spends on physical assets like machinery and facilities to support its operations.